p2dinc.com
P2D - About UsP2D Bioscience (P2D) is a specialty pharmaceutical company focused on developing innovative drugs for the treatment of central nervous system (CNS) inflammatory disorders including Frontotemporal Dementia (FTD) and Alzheimer’s disease (AD). P2D currently has a pipeline of drug candidates that are: 1) orally and centrally active isoindoline TNFα inhibitors for the treatment FTD and AD and 2) benztropine-analog DAT inhibitors for the treatment of.
http://www.p2dinc.com/